Clinical Trials Browser

Phase 2 × Glioma × Re-Irradiation × Clear all

NCT01743950 2025-01-08

A Phase II Study of Pulse Reduced Dose Rate Radiation Therapy With Bevacizumab

Phase 2 Terminated

Glioblastoma, Glioma